Scott Tarriff, CEO, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 30,085 shares at $41.52 ($1.2M) on 2019-02-01, disclosed to the SEC on 2019-02-04.
Open-market sale of $1.2M EGRX by CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.52 | 29,185 | $1.2M | 97.0% |
| 2 | $42.30 | 900 | $38K | 3.0% |
| Total | $41.54 avg | 30,085 | $1.2M | 100% |
| Filing → |
| EGRX | SELL | 2023-05-18 | $300K | — | Filing → |
| EGRX | SELL | 2023-05-15 | $1.2M | — | Filing → |
| EGRX | SELL | 2019-04-03 | $2.5M | — | Filing → |